Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review-Reference-Cited by-同舟云学术

Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review

Published:2018 Issue:4 Volume:61 Page:524
ISSN:2287-8572
Container-title:Obstetrics & Gynecology Science
language:en
Short-container-title:Obstet Gynecol Sci

Author:

Kim Myeong Seon¹,Choi Chel-Hun¹,Kim Tae-Joong¹,Lee Jeong-Won¹,Lee Jeeyun²,Bae Duk-Soo¹,Kim Byoung-Gie¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publisher

Korean Society of Obstetrics and Gynecology

Subject

Obstetrics and Gynecology

Link

https://synapse.koreamed.org/pdf/10.5468/ogs.2018.61.4.524

Reference17 articles.

1. Primary mucosal melanoma

2. Primary malignant melanoma of uterine cervix FIGO IIa1: A case report with 40months ongoing survival and literature review

3. Malignant melanoma of the uterine cervix: Case report and review of the literature

4. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amelanotic primary cervical malignant melanoma: A case report and review of literature;World Journal of Clinical Oncology;2024-07-24

2. Primary cervical malignant melanoma that was successfully treated with pembrolizumab: a case report and literature review;Frontiers in Oncology;2024-06-26

3. Primary Melanoma of the Cervix Uteri: A Systematic Review and Meta-Analysis of the Reported Cases;Biology;2023-03-02

4. Primary Malignant Melanoma of the Cervix: An Integrated Analysis of Case Reports and Series;Frontiers in Oncology;2022-06-22

5. Recurrent malignant melanoma of the uterine cervix treated with anti‑PD‑1 antibodies and anti‑CTLA‑4 antibodies: A case report;Molecular and Clinical Oncology;2022-01-17